Host metabolism balances microbial regulation of bile acid signalling – Nature
Robertson, R. C., Manges, A. R., Finlay, B. B. & Prendergast, A. J. The human microbiome and child growth — first 1000 days and beyond. Trends Microbiol. 27, 131–147 (2019).
Google Scholar
Fuchs, C. D. & Trauner, M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 19, 432–450 (2022).
Google Scholar
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678–693 (2008).
Google Scholar
Wahlstrom, A., Sayin, S. I., Marschall, H. U. & Backhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41–50 (2016).
Google Scholar
Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121–141 (2014).
Google Scholar
Blander, J. M., Longman, R. S., Iliev, I. D., Sonnenberg, G. F. & Artis, D. Regulation of inflammation by microbiota interactions with the host. Nat. Immunol. 18, 851–860 (2017).
Google Scholar
Hang, S. Y. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143–148 (2019).
Google Scholar
Morais, L. H., Schreiber, H. L. T. & Mazmanian, S. K. The gut microbiota–brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-020-00460-0 (2020).
Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55–71 (2021).
Google Scholar
Nicholson, J. K. et al. Host–gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
Google Scholar
Martin, A. M., Sun, E. W., Rogers, G. B. & Keating, D. J. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Front. Physiol. 10, 428 (2019).
Google Scholar
Molinaro, A., Wahlstrom, A. & Marschall, H. U. Role of bile acids in metabolic control. Trends Endocrinol. Metab. 29, 31–41 (2018).
Google Scholar
Ramírez-Pérez, O., Cruz-Ramón, V., Chinchilla-López, P. & Méndez-Sánchez, N. The role of the gut microbiota in bile acid metabolism. Ann. Hepatol. 16, s15–s20 (2017).
Google Scholar
Wang, H., Chen, J., Hollister, K., Sowers, L. C. & Forman, B. M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3, 543–553 (1999).
Google Scholar
Claudel, T., Staels, B. & Kuipers, F. The farnesoid X receptor — a molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 25, 2020–2031 (2005).
Google Scholar
Jiang, L., Zhang, H., Xiao, D., Wei, H. & Chen, Y. Farnesoid X receptor (FXR): structures and ligands. Comput. Struct. Biotechnol. J. 19, 2148–2159 (2021).
Google Scholar
Johnson, M. R., Barnes, S., Kwakye, J. B. & Diasio, R. B. Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from human liver. J. Biol. Chem. 266, 10227–10233 (1991).
Google Scholar
Killenberg, P. G. & Jordan, J. T. Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from rat liver. J. Biol. Chem. 253, 1005–1010 (1978).
Google Scholar
Funabashi, M. et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 582, 566–570 (2020).
Google Scholar
White, B. A., Lipsky, R. L., Fricke, R. J. & Hylemon, P. B. Bile acid induction specificity of 7α-dehydroxylase activity in an intestinal Eubacterium species. Steroids 35, 103–109 (1980).
Google Scholar
Jones, B. V., Begley, M., Hill, C., Gahan, C. G. & Marchesi, J. R. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl Acad. Sci. USA 105, 13580–13585 (2008).
Google Scholar
Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22–39 (2016).
Google Scholar
Pandak, W. M. & Kakiyama, G. The acidic pathway of bile acid synthesis: not just an alternative pathway. Liver Res. 3, 88–98 (2019).
Google Scholar
Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-β-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225–235 (2013).
Google Scholar
Sun, L. et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat. Med. 24, 1919–1929 (2018).
Google Scholar
Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362–1365 (1999).
Google Scholar
Reschly, E. J. et al. Evolution of the bile salt nuclear receptor FXR in vertebrates. J. Lipid Res. 49, 1577–1587 (2008).
Google Scholar
Chiang, J. Y. Bile acids: regulation of synthesis. J. Lipid Res. 50, 1955–1966 (2009).
Google Scholar
Brandman, O. & Meyer, T. Feedback loops shape cellular signals in space and time. Science 322, 390–395 (2008).
Google Scholar
Tautenhahn, R., Patti, G. J., Rinehart, D. & Siuzdak, G. XCMS Online: a web-based platform to process untargeted metabolomic data. Anal. Chem. 84, 5035–5039 (2012).
Google Scholar
Helf, M. J., Fox, B. W., Artyukhin, A. B., Zhang, Y. K. & Schroeder, F. C. Comparative metabolomics with Metaboseek reveals functions of a conserved fat metabolism pathway in C. elegans. Nat. Commun. 13, 782 (2022).
Google Scholar
Arifuzzaman, M. et al. Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation. Nature https://doi.org/10.1038/s41586-022-05380-y (2022).
Singh, V. et al. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175, 679–694.e22 (2018).
Google Scholar
Naquet, P., Kerr, E. W., Vickers, S. D. & Leonardi, R. Regulation of coenzyme A levels by degradation: the ‘ins and outs’. Prog. Lipid Res. 78, 101028 (2020).
Google Scholar
Hunt, M. C., Siponen, M. I. & Alexson, S. E. The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim. Biophys. Acta 1822, 1397–1410 (2012).
Google Scholar
Neugebauer, K. A. et al. BAAT gene knockout alters early life development and the gut microbiome and reveals unusual bile acids in mice. J. Lipid Res. 63, 100297 (2022).
Google Scholar
Bartucci, R., Salvati, A., Olinga, P. & Boersma, Y. L. Vanin 1: its physiological function and role in diseases. Int. J. Mol. Sci. 20, 3891 (2019).
Google Scholar
Kaskow, B. J., Proffitt, J. M., Blangero, J., Moses, E. K. & Abraham, L. J. Diverse biological activities of the vascular non-inflammatory molecules — the vanin pantetheinases. Biochem. Biophys. Res. Commun. 417, 653–658 (2012).
Google Scholar
Yu, H. et al. Vanin1 (VNN1) in chronic diseases: future directions for targeted therapy. Eur. J. Pharmacol. 962, 176220 (2024).
Google Scholar
Yao, L. et al. A selective gut bacterial bile salt hydrolase alters host metabolism. eLife https://doi.org/10.7554/eLife.37182 (2018).
Al-Dury, S., Wahlstrom, A., Stahlman, M., Backhed, F. & Marschall, H. U. Cyp3a11 is dispensable for the formation of murine bile acids. J. Hepatol. 64, S436 (2016).
Google Scholar
Guzior, D. V. et al. Bile salt hydrolase acyltransferase activity expands bile acid diversity. Nature https://doi.org/10.1038/s41586-024-07017-8 (2024).
Quinn, R. A. et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature 579, 123–129 (2020).
Google Scholar
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P. & Gronemeyer, H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 3667–3675 (1996).
Google Scholar
Willson, T. M., Jones, S. A., Moore, J. T. & Kliewer, S. A. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism. Med. Res. Rev. 21, 513–522 (2001).
Google Scholar
Jiang, C. et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun. 6, 10166 (2015).
Google Scholar
Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217–225 (2005).
Google Scholar
Kim, I. et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 48, 2664–2672 (2007).
Google Scholar
Gonzalez, F. J., Jiang, C., Xie, C. & Patterson, A. D. Intestinal farnesoid X receptor signaling modulates metabolic disease. Dig. Dis. 35, 178–184 (2017).
Google Scholar
Cheng, K. et al. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget 9, 25572–25585 (2018).
Google Scholar
Ito, S. et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J. Clin. Invest. 115, 2202–2208 (2005).
Google Scholar
Kuang, J. L. et al. Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut–liver axis. Cell Metab. 35, 1752–1766.e8 (2023).
Google Scholar
Song, X. Y. et al. Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis. Nature 577, 410–415 (2020).
Google Scholar
Campbell, C. et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581, 475–479 (2020).
Google Scholar
Einarsson, C., Hillebrant, C. G. & Axelson, M. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects. Hepatology 33, 1189–1193 (2001).
Google Scholar
Li, C. et al. Farnesoid X receptor agonists as therapeutic target for cardiometabolic diseases. Front. Pharmacol. 11, 1247 (2020).
Google Scholar
Ali, A. H., Carey, E. J. & Lindor, K. D. Recent advances in the development of farnesoid X receptor agonists. Ann. Transl. Med. 3, 5 (2015).
Google Scholar
Ferrell, J. M. & Chiang, J. Y. L. Understanding bile acid signaling in diabetes: from pathophysiology to therapeutic targets. Diabetes Metab. J. 43, 257–272 (2019).
Google Scholar
Li, T. & Apte, U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv. Pharmacol. 74, 263–302 (2015).
Google Scholar
Mahanti, P. et al. Comparative metabolomics reveals endogenous ligands of DAF-12, a nuclear hormone receptor, regulating C. elegans development and lifespan. Cell Metab. 19, 73–83 (2014).
Google Scholar
Pitari, G. et al. Pantetheinase activity of membrane-bound vanin-1: lack of free cysteamine in tissues of vanin-1 deficient mice. FEBS Lett. 483, 149–154 (2000).
Google Scholar
Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells. Science 348, 1031–1035 (2015).
Google Scholar
Letourneau, J. et al. Ecological memory of prior nutrient exposure in the human gut microbiome. ISME J. 16, 2479–2490 (2022).
Google Scholar
Goc, J. et al. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell 184, 5015–5030.e16 (2021).
Google Scholar
Tautenhahn, R., Bottcher, C. & Neumann, S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 9, 504 (2008).
Google Scholar
Wang, M. et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 34, 828–837 (2016).
Google Scholar
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
Google Scholar
Zhang, B. et al. Acylspermidines are conserved mitochondrial sirtuin-dependent metabolites. Nat. Chem. Biol. 20, 812–822 (2024).
Google Scholar
Parkhurst, C. Fiji oil red O macro. Zenodo https://doi.org/10.5281/zenodo.14031611 (2024).
